Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Mathilde Roumier, Romain Paule et al.|Journal of Clinical Immunology|2020Cited by 53
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, Marianne Asso‐Bonnet et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENTNathalie Morel, N. Costedoat‐Chalumeau, Y. Benhamou et al.|Retina|2021Cited by 13
A low level of CD16<sup>pos</sup> monocytes in SARS-CoV-2 infected patients is a marker of severityMarc Vasse, Tiffany Pascreau, Benjamin Zuber et al.|Clinical Chemistry and Laboratory Medicine (CCLM)|2021Cited by 8
Tocilizumab to Prevent Ventilatory Support for Severe Worsening COVID-19 Pneumonia: A Propensity Score AnalysisMathilde Roumier, Félix Ackermann, Romain Paule et al.|SSRN Electronic Journal|2020Cited by 1